Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University
|
September 8, 2025
[Avitinib suppresses NLRP3 inflammasome activation and ameliorates septic shock in mice]
Feifei Shang, Xiaoke Shi, Yao Zeng, et al.
Food & Function
|
September 13, 2022
Sennoside A is a novel inhibitor targeting caspase-1
Jiasi Wu, Yuejia Lan, Xiaoke Shi, et al.
Phytochemistry
|
October 16, 2020
Diterpenoids caryopterisoids D - Q and iridoid glucoside derivatives caryopterisides F - H from Caryopteris glutinosa
Xuejian Zhang, Ting Peng, Xiaoke Shi, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
November 25, 2024
Calcium Channel Blocker Lacidipine Promotes Antitumor Immunity by Reprogramming Tryptophan Metabolism
Yuwen Sheng, Chong Qiao, Zhonghui Zhang, et al.
International Immunopharmacology
|
January 9, 2026
Targeted alleviation of local inflammation by a hydroxypropyl-cyclodextrin-encapsulated prodrug of methyl salicylate and menthol though Nrf2/NF-κB pathway
Xuejian Zhang, Xiaoke Shi, Hong Xu, et al.
Journal of Medicinal Chemistry
|
November 19, 2024
Correction to "Discovery of a Covalent Inhibitor of Pro-Caspase-1 Zymogen Blocking NLRP3 Inflammasome Activation and Pyroptosis"
Dongyi Cao, Ruiying Xi, Hongye Li, et al.
Journal of Medicinal Chemistry
|
August 19, 2024
Discovery of a Covalent Inhibitor of Pro-Caspase-1 Zymogen Blocking NLRP3 Inflammasome Activation and Pyroptosis
Dongyi Cao, Ruiying Xi, Hongye Li, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 24, 2026
Self-assembled multicomponent prodrugs with GSH/ROS site-responsiveness enable spatiotemporally controlled release for treating resistant NSCLC
Chaozheng Zhang, Yao Chen, Xiaoke Shi, et al.
Molecular Oncology
|
October 18, 2015
5-Hydroxytryptamine promotes hepatocellular carcinoma proliferation by influencing β-catenin
Sarwat Fatima, Xiaoke Shi, Zesi Lin, et al.
Bioconjugate Chemistry
|
April 15, 2025
GSH-Responsive Heterodimeric Dual-Targeted Nanomedicine Modulates EMT to Conquer Paclitaxel-Induced Invasive Breast Cancer Metastasis
Ying Chen, Yao Chen, Hong Xu, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University
|
September 8, 2025
[Avitinib suppresses NLRP3 inflammasome activation and ameliorates septic shock in mice]
Feifei Shang, Xiaoke Shi, Yao Zeng, et al.
Food & Function
|
September 13, 2022
Sennoside A is a novel inhibitor targeting caspase-1
Jiasi Wu, Yuejia Lan, Xiaoke Shi, et al.
Phytochemistry
|
October 16, 2020
Diterpenoids caryopterisoids D - Q and iridoid glucoside derivatives caryopterisides F - H from Caryopteris glutinosa
Xuejian Zhang, Ting Peng, Xiaoke Shi, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
November 25, 2024
Calcium Channel Blocker Lacidipine Promotes Antitumor Immunity by Reprogramming Tryptophan Metabolism
Yuwen Sheng, Chong Qiao, Zhonghui Zhang, et al.
International Immunopharmacology
|
January 9, 2026
Targeted alleviation of local inflammation by a hydroxypropyl-cyclodextrin-encapsulated prodrug of methyl salicylate and menthol though Nrf2/NF-κB pathway
Xuejian Zhang, Xiaoke Shi, Hong Xu, et al.
Journal of Medicinal Chemistry
|
November 19, 2024
Correction to "Discovery of a Covalent Inhibitor of Pro-Caspase-1 Zymogen Blocking NLRP3 Inflammasome Activation and Pyroptosis"
Dongyi Cao, Ruiying Xi, Hongye Li, et al.
Journal of Medicinal Chemistry
|
August 19, 2024
Discovery of a Covalent Inhibitor of Pro-Caspase-1 Zymogen Blocking NLRP3 Inflammasome Activation and Pyroptosis
Dongyi Cao, Ruiying Xi, Hongye Li, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 24, 2026
Self-assembled multicomponent prodrugs with GSH/ROS site-responsiveness enable spatiotemporally controlled release for treating resistant NSCLC
Chaozheng Zhang, Yao Chen, Xiaoke Shi, et al.
Molecular Oncology
|
October 18, 2015
5-Hydroxytryptamine promotes hepatocellular carcinoma proliferation by influencing β-catenin
Sarwat Fatima, Xiaoke Shi, Zesi Lin, et al.
Bioconjugate Chemistry
|
April 15, 2025
GSH-Responsive Heterodimeric Dual-Targeted Nanomedicine Modulates EMT to Conquer Paclitaxel-Induced Invasive Breast Cancer Metastasis
Ying Chen, Yao Chen, Hong Xu, et al.
Page
of 2